Valuation: ResMed, Inc.

Market Cap 3.18TCr 2.74TCr 2.57TCr 2.35TCr 4.41TCr 3,03900Cr 4.47TCr 30TCr 12TCr 1,52300Cr 12TCr 12TCr 5,06500Cr P/E 2027 *
19.1x
P/E 2028 * 17.2x
Enterprise Value 3.08TCr 2.66TCr 2.5TCr 2.28TCr 4.28TCr 2,94900Cr 4.34TCr 29TCr 11TCr 1,47700Cr 12TCr 11TCr 4,91400Cr EV / Sales 2027 *
5.31x
EV / Sales 2028 * 4.87x
Free-Float
37.56%
Yield 2027 *
1.21%
Yield 2028 * 1.35%
1 day+0.89%
1 week-1.71%
Current month+4.74%
1 month+11.27%
3 months+8.25%
6 months-14.65%
Current year-8.25%
1 week 218.66
Extreme 218.655
228.55
1 month 190.21
Extreme 190.21
228.55
Current year 180.26
Extreme 180.265
277.67
1 year 180.26
Extreme 180.265
293.81
3 years 132.24
Extreme 132.24
293.81
5 years 132.24
Extreme 132.24
301.34
10 years 56.59
Extreme 56.59
301.34
Manager TitleAgeSince
Chief Executive Officer 53 01/03/2013
Director of Finance/CFO 40 04/05/2026
Chief Tech/Sci/R&D Officer - 01/02/2024
Director TitleAgeSince
Director/Board Member 78 01/01/2005
Chairman 53 25/01/2023
Chairman 83 01/06/1989
Date Insider Type Main position Quantity % Market Cap.
07/08/26 Fiscal year

Chief Executive Officer

14,973 0.0103%
05/08/26 Sell

Founder

-8,000 0.0055%
07/07/26 Fiscal year

Chief Executive Officer

14,973 0.0103%
Change 5-day change 1-year change 3-year change Capi.($)
+0.89%-1.71%-22.76%+33.39% 3.18TCr
+0.74%-2.95%+20.43%+10.29% 22TCr
-0.46%-3.24%-3.97%-20.16% 14TCr
+1.90%-1.13%-17.57%+38.73% 14TCr
-0.43%-0.13%-50.39%+1.86% 7.45TCr
+0.34%-2.95%+16.09%+18.70% 5.23TCr
+0.90%-0.61%-16.68%-13.54% 5.03TCr
+0.63%-0.54%+25.85%+24.69% 4.19TCr
-0.33%-2.36%+40.01%+50.07% 4.01TCr
+1.00%+0.40%-0.18%+6.85% 3.27TCr
Average +0.52%-0.46%-0.92%+15.09% 8.2TCr
Weighted average by Cap. +0.56%-1.11%-0.44%+11.53%

Financials

2027 *2028 *
Net sales 581.23Cr 501.78Cr 470.75Cr 428.77Cr 806.21Cr 56TCr 817.39Cr 5.52TCr 2.16TCr 28TCr 2.18TCr 2.13TCr 93TCr 618.74Cr 534.16Cr 501.13Cr 456.44Cr 858.24Cr 59TCr 870.14Cr 5.87TCr 2.3TCr 30TCr 2.32TCr 2.27TCr 99TCr
Net income 162.85Cr 140.59Cr 131.89Cr 120.13Cr 225.88Cr 16TCr 229.01Cr 1.55TCr 605.87Cr 7.8TCr 611.39Cr 598.15Cr 26TCr 178.12Cr 153.77Cr 144.26Cr 131.4Cr 247.07Cr 17TCr 250.5Cr 1.69TCr 662.71Cr 8.53TCr 668.75Cr 654.27Cr 28TCr
Net Debt -95Cr -82Cr -77Cr -70Cr -131.58Cr -9.07TCr -133.4Cr -900.63Cr -352.93Cr -4.54TCr -356.14Cr -348.43Cr -15TCr -163.35Cr -141.02Cr -132.3Cr -120.5Cr -226.57Cr -16TCr -229.71Cr -1.55TCr -607.73Cr -7.82TCr -613.27Cr -599.99Cr -26TCr
Logo ResMed, Inc.
ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows: - medical devices (51.8%); - masks (35.7%); - software as a service (12.5%): residential care management software solutions. At the end of June 2025, the group had 8 production sites located in the United States (3), Australia, China, Singapore, Malaysia and France. The United States accounts for 63.8% of net sales.
Employees
11,370
Date Price Change Volume
18/26/18 $220.99 +0.28% 1,49,834
17/26/17 $220.37 -1.82% 14,53,880
14/26/14 $224.46 -1.01% 11,93,129
13/26/13 $226.74 +0.33% 11,67,599
12/26/12 $226.00 +0.52% 14,03,347
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
220.37USD
Average target price
247.20USD
Spread / Average Target
+12.17%

Quarterly revenue - Rate of surprise